Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial

Objectives: To identify the lowest dose of Depo-Provera that, when administered off-label subcutaneously, suppressed ovulation and had a pharmacokinetic profile consistent with a 4-month contraceptive effect. Study Design: We conducted a randomized, multicenter, parallel-group study to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Vera, Fuchs, Rachael, Brache, Vivian, Bahamondes, Luis, Miranda, Maria Jose, Lendvay, Anja, Cochón, Leila, Taylor, Douglas, Dorflinger, Laneta J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551587/
https://www.ncbi.nlm.nih.gov/pubmed/34746745
http://dx.doi.org/10.1016/j.conx.2021.100070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551587/
https://www.ncbi.nlm.nih.gov/pubmed/34746745
http://dx.doi.org/10.1016/j.conx.2021.100070

Ejemplares similares